Auditors ✓ Lawyers ✓ Tax advisors ✓ and business consultants ✓ : Four perspectives. One solution. Worldwide. Learn …
Auditing and audit-related advice for companies ✓ Experienced auditors ✓ Excellent advice ✓ Tailor-made solutions » …
Our clients entrust us with their most important legal matters. Learn more about our legal services!
Tax laws are complex and dynamic. We face the challenge of tax law together with you - find out more.
Business consulting for companies ✓ Experienced consultants ✓ Excellent advice ✓ Tailor-made solutions » more
Baker Tilly advises ARKLYZ AG on the acquisition of Gabor Shoes GmbH
FUNKE acquires Chefkoch GmbH – Baker Tilly advises on the Transaction
EU Pay Transparency Directive – what companies can expect
New Partner in Real Estate Valuation: Baker Tilly Expands Advisory Services
Baker Tilly advises Rigeto: Matignon Group acquires MEON locations
EU “Omnibus” Package: Less effort for sustainability reporting?
Draft bills on Germany’s infrastructure fund: what matters after this strong signal
How far can the rights of a criminal defense insurer extend?
Emergency planning in the family business: Regulating responsibility in good time
Survey: Two thirds of German automotive suppliers anticipate a market shakeout
Regulating the Future: Web3 & Crypto
Data protection: German Federal Labor Court tightens requirements for the use of HR software
Cross-industry expertise for individual solutions ✓ Our interdisciplinary teams combine expertise & market …
Carve-out or collapse? How automotive suppliers are saving themselves.
Transparency requirement for electricity and gas concession selection procedures
Risk management ✓ Compliance and controls ✓ Increase and ensure security & conformity ✓ more»
Baker Tilly offers a wide range of individual and innovative consulting services. Find out more!
Find the right partners in order to maximize the value of your products or acquire new licenses. We help you to identify and integrate strategic partners for in- and out-licensing.
The increasing use of in- and out-licensing agreements in the healthcare sector is influenced by various factors. These include the high development costs and risks of new drugs and technologies, the lack of internal expertise and the need to expand the product and patent portfolio.
For biotech and pharmaceutical companies, licensing agreements open up opportunities to gain access to innovative technologies and new markets while reducing financial and organizational risks. This is particularly important in order to remain competitive in a constantly changing industry.
In order to take full advantage of the benefits of in- and out-licensing, it is crucial to deal with the associated challenges.
In-licensing
Out-licensing
Stephan Zuber
Partner
Attorney-at-Law (Rechtsanwalt), Specialist Lawyer for Commercial and Corporate Law
Talk to us - without any obligation
Get in touch
View all news
Help us improve this page.
Please select at least one of the following statements: